Peptide Atlas · Peptide

Melanotan I

Afamelanotide is an analogue of alpha-melanocyte-stimulating hormone, studied as a subcutaneous implant.

established

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

created page created as 'Melanotan I' with aliases Afamelanotide, Scenesse, CUV1647, MT-1, [Nle4,D-Phe7]-α-MSH, NDP-MSH · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
fact added identity: PubChem CID 16197727: Afamelanotide, C78H111N21O19, 1646.8 g/mol. · 2026-09-27 04:00 · somebody
fact added identity: CAS registry number 75921-69-6. · 2026-09-27 04:00 · somebody
fact added summary: Afamelanotide is an analogue of alpha-melanocyte-stimulating hormone, studied as a subcutaneous implant. · 2026-09-27 04:00 · somebody
fact added history: In two randomized placebo-controlled trials in erythropoietic protoporphyria, a severe light-sensitivity disorder, it wa · 2026-09-27 04:00 · somebody
fact added history: A long-term study of 115 patients treated with 1,023 implants over up to eight years at two porphyria centres recorded c · 2026-09-27 04:00 · somebody
citation added pmid 26132941 cited as established: Two randomized trials of afamelanotide in erythropoietic protoporphyria · 2026-09-27 04:00 · somebody
citation added pmid 25494545 cited as emerging: Long-term observational study in 115 patients · 2026-09-27 04:00 · somebody

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.